@biotechbeta biotechbeta

biotechbeta posts on X about $abvx, abstract, $tars, ecco the most. They currently have [---] followers and [--] posts still getting attention that total [------] engagements in the last [--] hours.

Engagements: [------] #

[--] Week [------] +2,610%
[--] Year [------] +23,534%

Mentions: [--] #

Followers: [---] #

[--] Week [---] +64%
[--] Month [---] +71%
[--] Months [---] +181%
[--] Year [---] +252%

CreatorRank: [-------] #

Social Influence

Social category influence stocks #5740 social networks technology brands celebrities currencies finance cryptocurrencies

Social topic influence $abvx #1, abstract, $tars, ecco, regulatory, more than, mod, $gild, $ftsv, lptx

Top accounts mentioned or mentioned by @lifescivc @huizhongwu @crocsanalyst @unemon1 @agent0088156721 @jackman724444 @biotech_jack @pawcio2009 @przemek2019

Top assets mentioned Abivax SA (ABVX) Tarsus Pharmaceuticals, Inc. (TARS) Gilead Sciences, Inc. (GILD) Eli Lilly and Company (LLY) AstraZeneca PLC (AZN) Johnson & Johnson (JNJ) Merck & Co., Inc. (MRK)

Top Social Posts

Top posts by engagements in the last [--] hours

"@LifeSciVC $GILD $FTSV magrolimab cd47 hold too"
X Link 2022-03-15T03:05Z [--] followers, [--] engagements

"@huizhong_wu incredibly asinine move blocking FOSUN / biontech mRNA vaccines in Q4 [----] - time to revax the whole population in [----] [----] and 2024"
X Link 2022-03-18T07:36Z [--] followers, [--] engagements

"$LPTX stifel on GDF-15"
X Link 2024-11-15T10:42Z [--] followers, [----] engagements

"$TARS expect salesforce impact to really kick-in Q1 into Q2"
X Link 2024-11-21T17:35Z [--] followers, [---] engagements

"I like it. previous thesis + tweet [--] months ago validated and $TARS continues to hire for salesforce. but look at the R&D and BD jump 👀 seeds are being planted today"
X Link 2025-10-16T19:43Z [--] followers, [---] engagements

"@CrocsAnalyst Kevin Tang Jackie Chan Or a very Hung man"
X Link 2025-11-03T22:19Z [--] followers, [---] engagements

"Don't forget that $DVAX chairman Scott Myers was on $TRIL BoD too"
X Link 2025-12-24T15:41Z [---] followers, [---] engagements

"1. $ABVX Marc and Centerview Eric Tokat are friends and have done biz before (source: webinar from earlier this month this was stated explicitly) [--]. We know that $LLY $AZN and $JNJ are potential suitors per rumors [--]. $LLY lead # of deals done with Centerview (source RA cap)"
X Link 2026-01-19T16:37Z [---] followers, [----] engagements

"@unemon1 $MRK SF folks with a BD/biz angle who could've visited $ABVX -- this was just the first five hits"
X Link 2026-02-09T12:35Z [---] followers, [----] engagements

"(1/n) $ABVX ECCO Abstract #1"
X Link 2026-02-16T17:01Z [---] followers, [----] engagements

"$ABVX new SVP Reg Affairs - currently already [--] reg affairs folks - regulatory execution risk reduced (FDA/EMA hurdles) - however long any deal takes they'll still need to clear their filings/submissions - to keep an eye out if they go at it alone (my hunch is no)"
X Link 2026-02-16T10:04Z [---] followers, 10.1K engagements

"(24/n) $ABVX TAKEAWAYS [--]. reframing obe as more than an anti-inflammatory. the fibrosis abstract is HUGE - If miR-124 modulation shows anti-fibrotic signal in IBD models theyre hinting at disease mod. In Crohns especially fibrosis = unmet need + surgical burden = higherSP"
X Link 2026-02-16T17:38Z [---] followers, [----] engagements

"jjaf231.030 -- Inhibition of fibroblast activation and reduced collagen deposition in IBD models via miR-124 modulation. If this translates the narrative shifts from inflammation control (UC) to potential disease modification. woah"
X Link 2026-02-16T17:38Z [---] followers, [---] engagements

"@Agent0088156721 yeah but you could make the counterargument that acquirer has a reg-team that has twice as much expertise + 10x bigger amplified across geographies"
X Link 2026-02-16T17:56Z [---] followers, [---] engagements

"(25/25) $ABVX Takeaways [--]. Do NOT see this as an academic exercise. It's a positioning campaign + laying the railway tracks for commercialization. Every discount pathway is closed now =higher buyout price commanded. FFS might BTC my [---] calls now /fin and happy lunar new year"
X Link 2026-02-16T17:41Z [---] followers, [----] engagements

"(23/n) $ABVX Early look at all [--] abstracts big takeaways below: [--]. $ABVX carpet bombed ECCO for good reason they are building a totality-of-evidence fortress around obefazimod in UC with every angle: subgroups duration biomarkers.its for regulatory and payer fasttracking"
X Link 2026-02-16T17:35Z [---] followers, [----] engagements

"(22/n) $ABVX Abstract #22 (last one)"
X Link 2026-02-16T17:19Z [---] followers, [----] engagements

"(21/n) $ABVX Abstract #21"
X Link 2026-02-16T17:18Z [---] followers, [----] engagements

"(20/n) $ABVX Abstract #20"
X Link 2026-02-16T17:18Z [---] followers, [----] engagements

"(19/n) $ABVX Abstract #19"
X Link 2026-02-16T17:17Z [---] followers, [----] engagements

"(18/n) $ABVX Abstract #18"
X Link 2026-02-16T17:16Z [---] followers, [----] engagements

"(17/n) $ABVX Abstract #17"
X Link 2026-02-16T17:16Z [---] followers, [----] engagements

"(16/n) $ABVX Abstract #16"
X Link 2026-02-16T17:15Z [---] followers, [----] engagements

"(15/n) $ABVX Abstract #15"
X Link 2026-02-16T17:14Z [---] followers, [----] engagements

"(14/n) $ABVX Abstract #14"
X Link 2026-02-16T17:13Z [---] followers, [---] engagements

"(13/n) $ABVX Abstract #13"
X Link 2026-02-16T17:13Z [---] followers, [---] engagements

"(12/n) $ABVX Abstract #12"
X Link 2026-02-16T17:12Z [---] followers, [----] engagements

"(11/n) $ABVX Abstract #11"
X Link 2026-02-16T17:11Z [---] followers, [---] engagements

"(10/n) $ABVX Abstract #10"
X Link 2026-02-16T17:10Z [---] followers, [---] engagements

"(9/n) $ABVX Abstract #9 (surprise: it's safe)"
X Link 2026-02-16T17:10Z [---] followers, [----] engagements

"(8/n) $ABVX Abstract #8"
X Link 2026-02-16T17:09Z [---] followers, [---] engagements

"(7/n) $ABVX Abstract #7"
X Link 2026-02-16T17:08Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing